Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Network
Open Access
- 1 August 2016
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (8) , 1440-1448
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U10HL069294)
- Eastern Cooperative Oncology Group (CA180820, CA180853, CA 180799)
- Southwest Oncology Group NCTN (U10 CA180888)
- National Heart, Lung and Blood Institute (U10HL069294)
- National Cancer Institute
- Alliance for Clinical Trials in Oncology (U10CA180821 and U10CA180882)
- ECOG-ACRIN Cancer Research Group (CA 180820, CA 180853, CA 180799)
- Southwest Oncology Group (U10CA180888)
This publication has 40 references indexed in Scilit:
- Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trialBlood, 2013
- Reduced-Intensity Allogeneic Transplantation Provides High Event-Free and Overall Survival in Patients with Advanced Indolent B Cell Malignancies: CALGB 109901Transplantation and Cellular Therapy, 2011
- Autologous versus Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Patients with Chemosensitive Follicular Non-Hodgkin Lymphoma beyond First Complete Response or First Partial ResponseTransplantation and Cellular Therapy, 2011
- Reduced intensity conditioning HLA identical sibling donor allogeneic stem cell transplantation for patients with follicular lymphoma: long-term follow-up from two prospective multicenter trialsHaematologica, 2010
- Allogeneic Transplants in Follicular Lymphoma: Higher Risk of Disease Progression after Reduced-Intensity Compared to Myeloablative ConditioningTransplantation and Cellular Therapy, 2008
- Long-Term Outcomes of Autologous Stem Cell Transplantation for Follicular Non-Hodgkin Lymphoma: Effect of Histological Grade and Follicular International Prognostic IndexTransplantation and Cellular Therapy, 2008
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Rituximab Responsive Refractory Acute Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2006
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958